Stealth-cap technology for light-emitting nanoparticles

November 14, 2018, Helmholtz Association of German Research Centres
Nanoparticles in the blood: The stealth-cap prevents blood components from adhering. The surface has been cross-linked by UV radiation (enlarged image section) and is therefore stable in biological systems. Credit: HZDR/K.Klunker/istockphoto/Thomas-Soellner/Molecuul

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the so-called "upconverting" nanoparticles that not only convert infrared light into UV-visible light, but also are water-soluble, remain stable in complex body fluids such as blood serum, and can be used to store medications. They have created a tool that could potentially make the fight against cancer significantly more effective. The researchers recently published their results in the journal Angewandte Chemie.

Nanoparticles are tiny structures, typically less than 100 nanometers in size, which is about 500 to 1000 times smaller than the thickness of a human hair. Such materials are receiving increasing attention for biomedical applications. If equipped with appropriate properties, they can reach almost any tissue in the human body via the bloodstream—turning into perfect body probes.

It has been known for some years that the distribution of nanoparticles in the body is essentially determined by their size and surface properties. Dr. Tanmaya Joshi at HZDR's Institute for Radiopharmaceutical Cancer Research says, "Upconverting nanomaterials are of great interest for biomedical imaging." "When stimulated with they can send out bright blue, green, or red signals. If we succeed in navigating such nano-probes to diseased tissues, it can be particularly useful for cancer diagnosis," the team's photochemist, Dr. Massimo Sgarzi, added.

However, these light upconverters show poor solubility in water or tissue fluids—a must-have feature before any diagnostic or therapeutic use could be imagined. For the HZDR team this was not a hindrance, but rather a challenge: "We used a unique polymer mixture to cover the particles," says Dr. Joshi, who joined HZDR in 2017 from Monash University, as a Humboldt Fellow. Adding this protective cover makes the light-transducing nanoparticles biocompatible. The biologist Dr. Kristof Zarschler adds: "The upconverters are now water-soluble and even have a neutral surface charge. Our research shows that this new cover can almost completely prevent the body's own substances (present in the ) from binding to the particles. In other words, the nanoparticles now seem to wear an invisibility cloak. This, we believe, will help to avoid their recognition and elimination by phagocytes of the immune system."

In order to keep the new nano-probes stable for weeks in a complex biological environment, the scientists photochemically link the components of the protective shell with each other: "We simply irradiated our with UV light. This creates additional bonds between the molecular components constituting the protective cover—much alike sewing together the individual parts of the cloak of invisibility with the help of , "explains the Ph.D. student, Anne Nsubuga. She further adds, "This shell is only a few nanometers thick, and may even be used for hiding other substances, for example, cancer drugs, which could be later on released in the tumour and destroy it."

Following this breakthrough, the team now intends to validate their current results in living organisms: "For this, we first have to carry out strictly regulated and ethically acceptable experiments on animals. Only when our stealth-cap technology works on these without any side effects, their medical potential will be explored in detail and their application on the patients can be considered," explains the group leader Dr. Holger Stephan cautiously.

Explore further: Antibodies from the desert as guides to diseased cells

More information: Anne Nsubuga et al, Towards Utilising Photocrosslinking of Polydiacetylenes for the Preparation of "Stealth" Upconverting Nanoparticles, Angewandte Chemie International Edition (2018). DOI: 10.1002/anie.201811003

Related Stories

Antibodies from the desert as guides to diseased cells

June 12, 2014

Nanoparticles are considered a promising approach in detecting and fighting tumour cells. The method has, however, often failed because the human immune system recognizes and rejects them before they can fulfil their function. ...

Gentle cancer treatment using nanoparticles works

August 3, 2016

Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within. Researchers from the Niels Bohr Institute and the Faculty ...

Recommended for you

Team invents method to shrink objects to the nanoscale

December 13, 2018

MIT researchers have invented a way to fabricate nanoscale 3-D objects of nearly any shape. They can also pattern the objects with a variety of useful materials, including metals, quantum dots, and DNA.

Engineers produce smallest 3-D transistor yet

December 10, 2018

Researchers from MIT and the University of Colorado have fabricated a 3-D transistor that's less than half the size of today's smallest commercial models. To do so, they developed a novel microfabrication technique that modifies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.